Development of a High-Sensitivity Glycoproteomics Approach for Fc-Specific Quantification of IgG Core Fucosylation in Traumatic Brain Injury
Journal of Proteome Research · 2026
DOI: 10.1021/acs.jproteome.5c01154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Sherifdeen Onigbinde und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas79409, United States. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Immunoglobulin G, Proteomics, Immunoglobulin Fc Fragments. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Welch Foundation, CH Foundation.
Abstract (Originalsprache)
Traumatic brain injury (TBI) triggers complex neuroinflammatory cascades that involve sustained immune activation and dysregulated antibody effector functions. Immunoglobulin G (IgG) Fc N-glycosylation, particularly core fucosylation, critically modulates immune signaling through altered Fcγ receptor (FcγR) interactions; however, its role in TBI remains unexplored. Here, we developed a high-sensitivity, mass spectrometry-based glycoproteomics method for the systematic analysis of IgG Fc core fucosylation dynamics following TBI. The approach integrates Fc-specific enzymatic truncation with GlycINATOR (EndoS2) and tryptic digestion, followed by high-resolution LC–MS/MS profiling, enabling confident identification of truncated Fc glycopeptides. Furthermore, a targeted parallel reaction monitoring (PRM) strategy allowed direct quantification of core fucosylated and afucosylated glycopeptides from 10 μg of crude serum protein, eliminating the need for IgG purification. Our results reveal time-dependent and subclass-specific remodeling of IgG Fc fucosylation postinjury, characterized by an overall reduction in fucosylated species and a relative increase in afucosylation. Collectively, this study establishes a scalable analytical platform for Fc-specific glycosylation profiling and identifies IgG core fucosylation as a candidate molecular indicator of immune dysregulation in TBI, providing new insights into post-traumatic immune regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas79409, United States.
- Centre for Neurotrauma, MultiOmics & Biomarkers (CNMB) Morehouse School of Medicine, Atlanta, Georgia30310-145, United States.
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina98122, Italy.
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania PA15213, United States.
ORCID-Profile: Firas Kobeissy, Yehia Mechref
Förderung
- NIGMS NIH HHS
- Welch Foundation
- CH Foundation
- National Institute of General Medical Sciences
Zitieren
APA
Onigbinde, S., Solomon, J., Sandilya, V., Daramola, O., Fowowe, M., Adeniyi, M., Kobeissy, F., Mondello, S., Puccio, A. M., & Mechref, Y. (2026). Development of a High-Sensitivity Glycoproteomics Approach for Fc-Specific Quantification of IgG Core Fucosylation in Traumatic Brain Injury. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c01154
Vancouver
Onigbinde S, Solomon J, Sandilya V, Daramola O, Fowowe M, Adeniyi M, et al. Development of a High-Sensitivity Glycoproteomics Approach for Fc-Specific Quantification of IgG Core Fucosylation in Traumatic Brain Injury. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.5c01154
BibTeX
@article{Onigbinde2026,
author = {Onigbinde, Sherifdeen and Solomon, Joy and Sandilya, Vishal and Daramola, Oluwatosin and Fowowe, Mojibola and Adeniyi, Moyinoluwa and Kobeissy, Firas and Mondello, Stefania and Puccio, Ava M and Mechref, Yehia},
title = {Development of a High-Sensitivity Glycoproteomics Approach for Fc-Specific Quantification of IgG Core Fucosylation in Traumatic Brain Injury},
journal = {Journal of Proteome Research},
year = {2026},
doi = {10.1021/acs.jproteome.5c01154}
}
EUVIMED